Milan, 4 June. (askanews) – Pharmaceuticals plays a strategic role for the economic growth and sustainable development of a country, thanks above all to the commitment of important multinationals in the sector such as Merck, which in Lombardy provides a notable contribution in terms of investments, innovation and value creation. “Merck’s commitment as a presence of value in the territory emerged from the Ambrosetti Report – explains Angela Rinaldi, Managing Director Merck Life Science Italia -. The commitment is from an economic point of view, and here Merck if we look at the GDP of Lombardy contributes with more than 100 million, but also from a social, cognitive and environmental point of view”.
This is demonstrated above all by the considerable investments in research and in the use of new technologies implemented by the biopharmaceutical multinational in the most critical phases of the pandemic. “For companies directly linked to the fight against Covid, Merck has been a fundamental partner – the manager further underlines -: therefore not a simple supplier but a fundamental partner, even managing to increase supplies, improve logistics, organize the supply chain, to provide all the services necessary for these companies to support the national health service and the Lombardy Region in the fight against Covid”.
This is also thanks to the typically Lombard model, which bets heavily on collaboration between the public and private sectors: “There is great willingness, both on the part of the public, therefore on our part, and on the part of the private sector, to collaborate. But how do we collaborate? We collaborate on ideas – says Alessandro Fermi, Councilor for University, Research, Innovation of the Lombardy Region -. On the topic of research and innovation we will make double the resources available compared to the old programming: therefore for the next 7 years there will be more than double the resources of the previous 7 years. The private individual today is the interlocutor who tells you how to spend it. The public that in a self-referential or if we want a little arrogant way says ‘I know very well how to use this money’, in my opinion will never work. Who in the field can objectively tell you how to spend these resources well? Who objectively works there.”
A model, the Lombard one, capable of increasing the competitiveness of businesses and, precisely for this reason, improving the attractiveness of the territory. “As the Lombardy Region we have worked in recent years to create a fertile ecosystem for companies in the Life Sciences supply chain, bring investments to Italy and develop investments in the public and private sectors: a loyal collaboration, from the world of universities, research and innovation , the institutions – points out Emanuele Monti, member of the Health Commission and president of the Social Sustainability, Home and Family Commission of the Lombardy Region –. On this, also in my new role in Aifa, the Italian Medicines Agency, there is the need to open up to the Regions, with an even stronger involvement, starting from patient associations, for the good and health of citizens but also to develop the economy of a strategic sector of the country”.
https://askanews.it/wp-content/uploads/2024/06/La-biofarmaceutica-e-la-sfida-dello-sviluppo-sostenibile.jpg 604_video_11003847|vd01 vd96|https://askanews.it/wp- content/uploads/2024/06/Biopharmaceutics-and-the-challenge-dello-sviluppo-sostenibile.jpg|04/06/2024 11:18:58|Biopharmaceutics and the challenge of sustainable development|Video|News, Videonews]
